OPKO Health ROE 2012-2025 | OPK
Current and historical return on equity (ROE) values for OPKO Health (OPK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OPKO Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.18B | $1.31B | -13.64% |
| 2025-06-30 | $-0.18B | $1.30B | -13.17% |
| 2025-03-31 | $-0.04B | $1.31B | -2.85% |
| 2024-12-31 | $-0.05B | $1.37B | -3.91% |
| 2024-09-30 | $-0.13B | $1.40B | -9.78% |
| 2024-06-30 | $-0.24B | $1.40B | -17.66% |
| 2024-03-31 | $-0.25B | $1.25B | -17.93% |
| 2023-12-31 | $-0.19B | $1.39B | -12.70% |
| 2023-09-30 | $-0.21B | $1.45B | -13.59% |
| 2023-06-30 | $-0.21B | $1.54B | -13.32% |
| 2023-03-31 | $-0.29B | $1.55B | -18.01% |
| 2022-12-31 | $-0.33B | $1.56B | -20.11% |
| 2022-09-30 | $-0.32B | $1.63B | -19.07% |
| 2022-06-30 | $-0.20B | $1.72B | -11.91% |
| 2022-03-31 | $-0.12B | $1.62B | -6.81% |
| 2021-12-31 | $-0.03B | $1.69B | -1.74% |
| 2021-09-30 | $0.08B | $1.77B | 4.42% |
| 2021-06-30 | $0.07B | $1.74B | 4.22% |
| 2021-03-31 | $0.12B | $1.70B | 7.35% |
| 2020-12-31 | $0.03B | $1.67B | 1.93% |
| 2020-09-30 | $-0.11B | $1.62B | -7.09% |
| 2020-06-30 | $-0.20B | $1.59B | -12.45% |
| 2020-03-31 | $-0.29B | $1.55B | -17.99% |
| 2019-12-31 | $-0.32B | $1.62B | -18.72% |
| 2019-09-30 | $-0.28B | $1.64B | -16.16% |
| 2019-06-30 | $-0.25B | $1.71B | -13.90% |
| 2019-03-31 | $-0.19B | $1.76B | -10.68% |
| 2018-12-31 | $-0.15B | $1.79B | -8.48% |
| 2018-09-30 | $-0.30B | $1.79B | -16.24% |
| 2018-06-30 | $-0.30B | $1.81B | -16.02% |
| 2018-03-31 | $-0.31B | $1.82B | -15.97% |
| 2017-12-31 | $-0.31B | $1.84B | -15.02% |
| 2017-09-30 | $-0.13B | $2.09B | -5.96% |
| 2017-06-30 | $-0.10B | $2.11B | -4.95% |
| 2017-03-31 | $-0.07B | $2.11B | -3.41% |
| 2016-12-31 | $-0.05B | $2.09B | -2.34% |
| 2016-09-30 | $-0.01B | $2.11B | -0.44% |
| 2016-06-30 | $0.13B | $2.02B | 6.73% |
| 2016-03-31 | $0.08B | $2.00B | 4.43% |
| 2015-12-31 | $-0.03B | $1.98B | -2.15% |
| 2015-09-30 | $-0.09B | $1.97B | -7.65% |
| 2015-06-30 | $-0.26B | $0.83B | -31.16% |
| 2015-03-31 | $-0.24B | $0.81B | -28.30% |
| 2014-12-31 | $-0.17B | $0.84B | -19.84% |
| 2014-09-30 | $-0.14B | $0.89B | -15.53% |
| 2014-06-30 | $-0.15B | $0.91B | -16.87% |
| 2014-03-31 | $-0.13B | $0.83B | -17.34% |
| 2013-12-31 | $-0.12B | $0.87B | -19.38% |
| 2013-09-30 | $-0.10B | $0.87B | -23.59% |
| 2013-06-30 | $-0.05B | $0.31B | -20.48% |
| 2013-03-31 | $-0.06B | $0.32B | -28.61% |
| 2012-12-31 | $-0.03B | $0.18B | -19.62% |
| 2012-09-30 | $-0.01B | $0.15B | -7.82% |
| 2012-06-30 | $-0.01B | $0.15B | -7.72% |
| 2012-03-31 | $-0.01B | $0.16B | -4.54% |
| 2011-12-31 | $0.00B | $0.16B | -2.41% |
| 2011-09-30 | $-0.02B | $0.10B | -24.44% |
| 2011-06-30 | $-0.02B | $0.11B | -30.22% |
| 2011-03-31 | $-0.02B | $0.12B | -40.55% |
| 2010-12-31 | $-0.02B | $0.02B | -56.38% |
| 2010-09-30 | $-0.03B | $0.02B | -75.95% |
| 2010-06-30 | $-0.03B | $0.05B | -63.37% |
| 2010-03-31 | $-0.03B | $0.06B | -64.92% |
| 2009-12-31 | $-0.04B | $0.03B | -110.24% |
| 2009-09-30 | $-0.04B | $0.06B | -147.37% |
| 2009-06-30 | $-0.03B | $0.04B | -330.00% |
| 2009-03-31 | $-0.04B | $-0.01B | -7600.00% |
| 2008-12-31 | $-0.04B | $0.00B | -842.11% |
| 2008-09-30 | $-0.04B | $0.01B | -433.33% |
| 2008-06-30 | $-0.03B | $0.00B | -500.00% |
| 2008-03-31 | $-0.03B | $0.01B | -480.00% |
| 2007-12-31 | $-0.27B | $0.02B | -4678.26% |
| 2007-09-30 | $-0.01B | $0.00B | -666.67% |
| 2007-06-30 | $-0.01B | $0.00B | -258.82% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | -15.38% |
| 2006-09-30 | $-0.25B | $0.01B | -2868.57% |
| 2006-06-30 | $-0.25B | $0.01B | -2777.78% |
| 2006-03-31 | $-0.25B | $0.01B | -2777.78% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| 2005-09-30 | $0.00B | $0.01B | 0.00% |
| 2005-06-30 | $0.00B | $0.01B | -10.81% |
| 2005-03-31 | $0.00B | $0.01B | -21.62% |
| 2004-12-31 | $0.00B | $0.01B | -21.05% |
| 2004-09-30 | $0.00B | $0.01B | -42.11% |
| 2004-06-30 | $-0.01B | $0.01B | -58.54% |
| 2004-03-31 | $-0.01B | $0.01B | -62.22% |
| 2003-12-31 | $-0.01B | $0.01B | -56.00% |
| 2003-09-30 | $-0.01B | $0.01B | -64.29% |
| 2003-06-30 | $-0.01B | $0.01B | -62.50% |
| 2003-03-31 | $-0.01B | $0.02B | -54.05% |
| 2002-12-31 | $-0.01B | $0.02B | -53.01% |
| 2002-09-30 | $-0.01B | $0.02B | -38.71% |
| 2002-06-30 | $-0.01B | $0.02B | -35.64% |
| 2002-03-31 | $-0.01B | $0.02B | -36.70% |
| 2001-12-31 | $-0.01B | $0.03B | -33.61% |
| 2001-09-30 | $-0.01B | $0.03B | -27.91% |
| 2001-06-30 | $-0.01B | $0.03B | -23.19% |
| 2001-03-31 | $-0.01B | $0.03B | -16.55% |
| 2000-12-31 | $-0.01B | $0.04B | -18.90% |
| 2000-09-30 | $-0.01B | $0.04B | -25.53% |
| 2000-06-30 | $-0.01B | $0.04B | -32.79% |
| 2000-03-31 | $-0.01B | $0.02B | -71.43% |
| 1999-12-31 | $0.00B | $0.00B | -94.12% |
| 1999-09-30 | $0.00B | $0.00B | -80.00% |
| 1999-06-30 | $0.00B | $0.01B | -69.57% |
| 1999-03-31 | $0.00B | $0.01B | -46.15% |
| 1998-12-31 | $0.00B | $0.01B | -57.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.983B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Alcon (ALC) | Switzerland | $0.000B | 26.33 |